In the current review, we aim to highlight SOX4 and SOX11 transcription factors as a diagnostic biomarker and therapeutic targets of arthritis diseases, and to clarify their role in regulating osteoarthritis and rheumatoid arthritis in relation to the involved downstream and upstream signaling molecules. This evidence concerns the gene SOX11 and osteoarthritis.